This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors (PACAomics)

This study is currently recruiting participants.
See Contacts and Locations
Verified August 2016 by Institut Paoli-Calmettes
Information provided by (Responsible Party):
Institut Paoli-Calmettes Identifier:
First received: September 14, 2012
Last updated: June 20, 2017
Last verified: August 2016

Pancreatic cancer is among the most serious human neoplasia and the most difficult to treat.

Most patients present at diagnosis a non resectable, locally advanced or metastatic disease, with a median survival of 12 month.

The aim of this study is the identification of diagnosis biomarkers, predictive of the therapeutic response.

This project investigate the use of molecular analyses applied to pancreatic tumor cells collected by microbiopsy under ultrasound-endoscopy, and blood cells.

Condition Intervention
Pancreatic Tumor Procedure: suspected pancreatic tumor

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Research for Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors - PACAomics / IPC 2011-004

Resource links provided by NLM:

Further study details as provided by Institut Paoli-Calmettes:

Primary Outcome Measures:
  • Biomarkers [ Time Frame: within twenty four hours ]
    Genomics, transcriptomics and proteomics analyses to determine presence or absence of biomarkers

Secondary Outcome Measures:
  • Histology [ Time Frame: within twenty four hours ]
    To determine the histologic characteristics of the pancreatic tumor

Estimated Enrollment: 300
Study Start Date: February 2012
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: suspected pancreatic tumor
Realization of pancreatic tumor biopsy and blood samples
Procedure: suspected pancreatic tumor
Realization of pancreatic surgery to obtain tumor biopsy and blood samples to realize biomarkers analyses.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Suspicion of pancreatic adenocarcinoma
  • Patient > 18 years old
  • Social Security affiliation
  • Signed informed consent

Exclusion Criteria:

  • Patient in emergency situation
  • Major person being the object of a legal protective measure or unable to express its consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01692873

Contact: Dominique GENRE, MD 33 (0)4 91 22 37 78
Contact: Agnès BOYER CHAMMARD, MD 33 (0)4 91 22 37 78

Marine GILABERT, MD Recruiting
Marseille, France, 13009
Sponsors and Collaborators
Institut Paoli-Calmettes
Principal Investigator: Marine GILABERT, MD Institut Paoli-Calmettes
  More Information

Additional Information:
Responsible Party: Institut Paoli-Calmettes Identifier: NCT01692873     History of Changes
Other Study ID Numbers: PACAomics / IPC 2011-004
Study First Received: September 14, 2012
Last Updated: June 20, 2017

Keywords provided by Institut Paoli-Calmettes:
pancreatic tumor

Additional relevant MeSH terms:
Pancreatic Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Endocrine Gland Neoplasms
Digestive System Diseases
Pancreatic Diseases
Endocrine System Diseases processed this record on September 21, 2017